These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4467054)

  • 1. [Relation between the pressure response to spironolactone and or propranolol and the arterial hypertension pattern].
    Chiarini C; Degli Esposti E; Zuccalà A; Bellanova B; Zucchelli P
    Minerva Nefrol; 1974; 21(4):334-9. PubMed ID: 4467054
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 3. [The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension].
    Mauro B; Savagnone E
    Boll Soc Ital Cardiol; 1979; 24(2):189-96. PubMed ID: 548094
    [No Abstract]   [Full Text] [Related]  

  • 4. Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
    Dustan HP; Tarazi RC; Bravo EL
    N Engl J Med; 1972 Apr; 286(16):861-6. PubMed ID: 5061070
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone and propranolol in the management of hypertension.
    Akbar fA; Pearce MY
    Br J Clin Pract; 1984 Mar; 38(3):110-4. PubMed ID: 6370284
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypotensive effect of spironolactone in patients with essential hypertension and aldosterone regulation disorders].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Med Welt; 1980 Aug; 31(31-32):1135-7. PubMed ID: 7421547
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of propranolol in permanent essential hypertension].
    Safar M; Weiss Y; Simon A; Lehner JP; Milliez P
    Ann Med Interne (Paris); 1975 Nov; 126(11):737-43. PubMed ID: 1211699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 9. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
    J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].
    Gutiérrez Millet V; Casado Pérez S; Ruilope Urioste LM; Hernando Avendaño L
    Rev Clin Esp; 1975 Apr; 137(2):105-14. PubMed ID: 1144838
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
    Adlin EV; Marks AD; Channick BJ
    Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Inderal on certain hemodynamic indices in arterial hypertension].
    Kocemba J; Dubiel J; Gabryś B
    Pol Tyg Lek; 1970 Aug; 25(34):1280-2. PubMed ID: 5507157
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.
    Stokes GS; Weber MA; Thornell IR; Stoker LM
    Prog Biochem Pharmacol; 1974; 9():29-44. PubMed ID: 4612559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of spironolactone and hydrochlorothiazide on blood pressure levels and blood potassium. Controlled studies on hypertensive patients].
    Ambrosioni E; Costa FV; Magnani B
    G Clin Med; 1974 Nov; 55(11):782-97. PubMed ID: 4469883
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist.
    Johnston LC; Grieble HG
    Arch Intern Med; 1967 Mar; 119(3):225-31. PubMed ID: 6020067
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites.
    Nevens F; Lijnen P; VanBilloen H; Fevery J
    Hepatology; 1996 May; 23(5):1047-52. PubMed ID: 8621132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Echo- and phonomechanocardiographic evaluation of left ventricular function and total peripheral resistance during treatment of systemic arterial hypertension with pindolol and propranolol. A comparative study].
    Cantarelli EL; Pereira R; Garret M; Moreira CR
    Arq Bras Cardiol; 1986 Jan; 46(1):59-63. PubMed ID: 3813925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.